These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 23735618)
1. Canine melanoma diagnosis: RACK1 as a potential biological marker. Campagne C; Julé S; Alleaume C; Bernex F; Ezagal J; Château-Joubert S; Estrada M; Aubin-Houzelstein G; Panthier JJ; Egidy G Vet Pathol; 2013 Nov; 50(6):1083-90. PubMed ID: 23735618 [TBL] [Abstract][Full Text] [Related]
2. C-kit expression in canine mucosal melanomas. Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314 [TBL] [Abstract][Full Text] [Related]
3. RACK1, a clue to the diagnosis of cutaneous melanomas in horses. Campagne C; Julé S; Bernex F; Estrada M; Aubin-Houzelstein G; Panthier JJ; Egidy G BMC Vet Res; 2012 Jun; 8():95. PubMed ID: 22747534 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of tenascin in melanocytic tumours of dogs. Sevastre B; van Ederen AM; Terlou M; Gruys E; Nederbragt H J Comp Pathol; 2007 Jan; 136(1):49-56. PubMed ID: 17258226 [TBL] [Abstract][Full Text] [Related]
5. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831 [TBL] [Abstract][Full Text] [Related]
6. Fascin-1 expression in canine cutaneous and oral melanocytic tumours. Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355 [TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic significance of angiogenesis in canine melanocytic tumours. Cuitiño MC; Massone AR; Idiart JR J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819 [TBL] [Abstract][Full Text] [Related]
8. Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation. Egidy G; Julé S; Bossé P; Bernex F; Geffrotin C; Vincent-Naulleau S; Horak V; Sastre-Garau X; Panthier JJ Mol Cancer; 2008 Apr; 7():34. PubMed ID: 18442364 [TBL] [Abstract][Full Text] [Related]
9. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR; El-Zammar O Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [TBL] [Abstract][Full Text] [Related]
10. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis. Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions. Nielsen PS; Riber-Hansen R; Steiniche T Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457 [TBL] [Abstract][Full Text] [Related]
12. FoxP3 and IDO in Canine Melanocytic Tumors. Porcellato I; Brachelente C; De Paolis L; Menchetti L; Silvestri S; Sforna M; Vichi G; Iussich S; Mechelli L Vet Pathol; 2019 Mar; 56(2):189-199. PubMed ID: 30381008 [TBL] [Abstract][Full Text] [Related]
13. Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms. O'Reilly FM; Brat DJ; McAlpine BE; Grossniklaus HE; Folpe AL; Arbiser JL J Am Acad Dermatol; 2001 Sep; 45(3):414-9. PubMed ID: 11511840 [TBL] [Abstract][Full Text] [Related]
14. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. Roels S; Tilmant K; Ducatelle R J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290 [TBL] [Abstract][Full Text] [Related]
15. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas. Fröhlich E; Mack AF; Garbe C; Klessen C Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652 [TBL] [Abstract][Full Text] [Related]
19. MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma. Laprie C; Abadie J; Amardeilh MF; Net JL; Lagadic M; Delverdier M Vet Dermatol; 2001 Jun; 12(3):139-47. PubMed ID: 11420929 [TBL] [Abstract][Full Text] [Related]
20. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma. Gleason BC; Nascimento AF Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]